PATENT CLAIM ANALYSIS

Application Number: 15992287
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "282000"]

Abstract:
The invention describes pharmaceutical compounds and compositions comprised of a ligand attached to the opioid oxycodone, in a manner that substantially decreases or deters the potential for opioid abuse, addiction, illicit and illegal use, and overdose. When delivered at the proper dosage, the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent.

Claim (Index 11):
An oxycodone prodrug of the following formula where the prodrug moiety X is attached covalently to the oxycodone molecule via the 6 position ketone enolate oxygen as the enolate ester, or a pharmaceutically acceptable salt thereof, wherein X is represented by Ligand 17: wherein FA is C8 to C20 saturated or unsaturated, linear or branched, fatty acids.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 93.0
- Lexical Diversity: 1.36957
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15472758', '14953392', '14956143', '10800898', '11635788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8213899957990621
- 35 USC 102 Novelty (BERT): 0.5534060709657197
- Combined Prediction Score: 0.7945916033157279
- Mean Citation Score: 336.180702
- Max Citation Score: 418.85843
- Similarity Product: 350.5862587164641

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test